Rafi HofsteinPresident & CEO
Dr. Raphael Hofstein joined TIAP (then MaRS Innovation) as President & CEO in 2009, the year of the organization’s inception. Under Dr. Hofstein’s leadership, TIAP has incorporated over 50 startup companies; attracted over $300M in seed funding; and has become a key leader in bringing global industry focus on Toronto as a place of important research and commercialization activities.
Dr. Hofstein is a co-founder and director of BiolineRx in Israel (listed on NASDAQ), and of Triphase Accelerator Corporation, Canada’s largest oncology oriented accelerator. Dr. Hofstein is a member of the Executive Committee of Life Science Ontario, and is the Chair of the Board of Clinical Trials Ontario.
Dr. Hofstein received his PhD in Life Sciences and Chemistry from the Weizmann Institute of Science in Israel and completed post-doctoral training and research at the Harvard Medical School in Boston.